European registry elucidates safety outcomes of ventricular arrhythmia treatment with Affera system
A novel cardiac ablation system may hold the potential to improve upon the currently available treatments for ventricular arrhythmia (VA) patients, having demonstrated positive...
Post-TAVI pacemaker implantation linked to long-term increase in mortality rates
Pacemaker implantation within 30 days after a transcatheter aortic valve implantation (TAVI) procedure has been found to correlate with significantly higher rates of all-cause...
Medtronic announces first patient enrolment in trial assessing VT treatment with Affera system and...
Medtronic recently announced that the first patient has been enrolled in a US Food and Drug Administration (FDA) early feasibility study evaluating the Affera...
Biological heart age measured via AI analyses of ECG data could predict mortality and...
A new study presented by researchers at the 2025 European Heart Rhythm Association (EHRA) congress (30 March–1 April, Vienna, Austria) demonstrates how, using artificial...
